FIGORILLI, MICHELA
 Distribuzione geografica
Continente #
EU - Europa 170.712
NA - Nord America 5.306
AS - Asia 1.127
OC - Oceania 52
SA - Sud America 29
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 177.240
Nazione #
IT - Italia 169.073
US - Stati Uniti d'America 5.240
CN - Cina 648
SE - Svezia 554
DE - Germania 302
UA - Ucraina 262
SG - Singapore 243
GB - Regno Unito 160
FI - Finlandia 138
KR - Corea 91
FR - Francia 86
CA - Canada 53
AU - Australia 49
CZ - Repubblica Ceca 27
NL - Olanda 27
HK - Hong Kong 25
IN - India 24
IR - Iran 19
TR - Turchia 19
BR - Brasile 15
IL - Israele 15
AT - Austria 13
IE - Irlanda 11
VN - Vietnam 11
MX - Messico 10
BE - Belgio 9
CH - Svizzera 9
EG - Egitto 8
RU - Federazione Russa 8
ES - Italia 7
RO - Romania 7
JP - Giappone 6
CL - Cile 5
CX - Isole del Natale 5
PH - Filippine 5
RS - Serbia 5
UY - Uruguay 5
AR - Argentina 4
IQ - Iraq 4
TW - Taiwan 4
ID - Indonesia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
PK - Pakistan 2
TH - Thailandia 2
AM - Armenia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
LT - Lituania 1
MU - Mauritius 1
NG - Nigeria 1
Totale 177.240
Città #
Cagliari 164.444
Uta 3.159
Fairfield 640
Chandler 572
Woodbridge 453
Nyköping 439
Boardman 391
Houston 308
Ashburn 300
Wilmington 285
Seattle 234
Cambridge 230
Ann Arbor 195
Shanghai 176
Dearborn 172
Jacksonville 130
New York 126
Beijing 103
Helsinki 103
Augusta 98
Singapore 96
Boston 95
Rome 92
Milan 80
Nanjing 75
Seoul 73
Redwood City 58
San Diego 49
Bologna 29
Los Angeles 27
Jiaxing 25
Shenyang 24
Olbia 23
Nanchang 22
San Mateo 22
Guangzhou 21
Monza 21
Toronto 20
Brno 19
Finale Ligure 19
Turin 19
Carbonia 18
Naples 18
Syracuse 18
Atlanta 17
Galatina 16
Sassari 15
Hobart 14
Melbourne 14
Chicago 13
Hebei 13
Norwalk 13
Tramatza 13
London 12
Vienna 12
Villanovafranca 12
Changsha 11
Leipzig 11
Mountain View 11
Paris 11
Verona 11
Capoterra 10
Dublin 10
Hong Kong 10
Montréal 10
Padova 10
Wuhan 10
Quartu Sant'elena 9
Selargius 9
Shenzhen 9
Dong Ket 8
Frankfurt am Main 8
Hangzhou 8
Hefei 8
Jinan 8
Launceston 8
Tianjin 8
Amsterdam 7
Bari 7
Dolianova 7
Istanbul 7
Kunming 7
Leawood 7
Livorno 7
Montreal 7
Parma 7
Sestu 7
Sìnnai 7
Wuxi 7
Zapopan 7
Zhengzhou 7
Ardabil 6
Cairo 6
Chieti 6
Ferrara 6
Hounslow 6
Latina 6
Montesilvano Marina 6
Mumbai 6
Orange 6
Totale 174.035
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.163
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.551
F-Wave duration as a specific and sensitive tool for the diagnosis of restless legs syndrome/Willis-Ekbom disease 3.294
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.177
REM Sleep without atonia correlates with abnormal vestibular-evoked myogenic potentials in isolated REM sleep behavior disorder 2.597
Overlap Parasomnia Disorder in a case of Creutzfeldt-Jakob Disease 2.459
Presurgical bariatric evaluation of sleep-disordered breathing in morbidly obese patients: sleep disruption and cognitive impairment 2.408
Confusional arousal in moderate Alzheimer disease: a case description 2.379
Clinical and genetic characteristics of late-onset Huntington's disease 2.230
Clinical manifestations of intermediate allele carriers in Huntington disease 2.201
Startle Reflex as a possible biomarker associated with REM sleep behavior disorders in the prodromal stage of Parkinson's disease 2.186
Neurocognitive profile of patients with nocturnal frontal lobe epilepsy 2.183
Specificity and sensitivity of F-waves parameters in diagnosis of RLS/WED 2.137
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.136
Diffusion Tensor Imaging Tractography and MRI Perfusion in Post Traumatic Brain Injury Hypersomnia 2.131
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.097
Modulation of the Startle Response in REM Sleep Behavior Disorder 2.088
Neuropsychological and neurocognitive profile in posttraumatic brain injury hypersomnia 2.045
Occurence and DAergic therapy correlates of REM sleep behavior disorder in patients with Parkinson Disease 2.042
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.042
Diffusion Tensor Imaging Tractography in Post Traumatic Brain Injury Hypersomnia 2.020
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 1.999
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 1.997
Effects of nocturnal ventilatory treatment in cognitive functions in a cohort of patients affected by OHS 1.995
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 1.944
OBSERVATIONAL STUDY ON PREVALENCE OF SLEEP DISTURBANCE IN A MULTICENTRIC COHORT OF ITALIAN PHYSICIANS. 1.909
Severity of REM sleep muscle atonia loss in idiopathic REM sleep behavior disorder correlates with abnormalities in the Vestibular Evoked Myogenic Potentials 1.904
SEVERITY OF REM SLEEP MUSCLE ATONIA LOSS IN IDIOPATHIC REM SLEEP BEHAVIOUR DISORDER CORRELATES WITH THE DEGREE OF ABNORMALITIES IN THE VESTIBULAR EVOKED MYOGENIC POTENTIALS 1.890
Sleep in Parkinson’s Disease with Impulse Control Disorder 1.824
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder 1.795
Discordance between Dopamine transporter deficit and motor symptoms in a case of REM sleep behavior disorder 1.769
Severe SAS in a case of proopiomelanocortin (POMC) deficiency 1.705
Role of DA-ergic therapy on REM sleep behaviour disorder in a large population of Parkinsonians 1.671
Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder 1.638
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.627
Prevalence of sleep disorders and determinants of sleepiness in a multicentric cohort of italian physicians 1.602
The vestibular evoked myogenic potentials as a new tool to investigate brainstem dysfunctions in REM sleep behavior disorder 1.554
null 1.548
Periodic leg movements during sleep and cardiovascular and/or cerebrovascular morbidity 1.540
Does REM sleep behavior disorder change in the progression of Parkinson’s disease? 1.533
null 1.494
Vestibular evoked myogenic potentials are abnormal in idiopathic REM sleep behavior disorder 1.443
Diagnosing REM sleep behavior disorder in Parkinson's disease without a gold standard: a latent-class model study 1.421
null 1.368
The clinical importance of periodic leg movements in sleep 1.354
Cardiac autonomic dynamics during sleep are lost in patients with TIA and stroke 1.348
Sleep disorders in night workers: effect of the shiftwork rotation scheme 1.347
Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies 1.332
DIAGNOSING REM SLEEP BEHAVIOUR DISORDER IN PARKINSON DISEASE WITHOUT A GOLD STANDARD: A LATENT CLASSES MODELS STUDY 1.312
Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease? 1.271
Studio caso-controllo sugli effetti cognitivo-comportamentali dell’instabilità del sonno NREM in pazienti affetti da parasonnie NREM ed epilessia con crisi ipermotorie in sonno (SHE). 1.266
SMPD1 variants do not have a major role in REM sleep behavior disorder 1.264
Clinical evaluation of sleep disorders in a large population of Parkinsonians 1.255
Absence of cardiovascular autonomic modulation during sleep in patients with acute ischemic stroke: an analysis of the SAS-CARE study cohort 1.251
REM sleep behavior disorder changes in the progression of Parkinson's disease: a longitudinal study 1.235
91. Neurophysiological evaluation of spinal excitability in patients affected by primitive restless legs syndrome 1.210
Occurrence and Daergic therapy correlates of REM sleep behaviour disorder in a large population of patients with Parkinson's disease 1.200
GBA variants in REM sleep behavior disorder: a multicenter study 1.190
Prevalence of sleep disturbance and determinants of sleepiness in a cohort of Italian hospital physicians: the PRESOMO Study 1.112
Neurophysiological evaluation of spinal excitability in primary Restless Legs Syndrome. 1.110
Cardiovascular autonomic control during sleep in patients with acute ischemic stroke 1.085
Gender differences in the adjustment to night shift work 1.079
Dream mentation and impulse control disorder (ICD) in Parkinson's disease (PD) 1.074
Prevalence of sleep disruption and determinants of sleepiness in a cohort of Italian hospital physicians: The PRESOMO study 1.061
RBD-Score and DA-ergic theraphy in Parkinson disease: the controversial role of D1-receptors in REM sleep Behavior disorder pathophysiology. 1.032
Neurobiology of Sleep-Related Movements 991
Neurophysiological investigation of brainstem in idiopathic REM sleep behavior disorder (iRBD) through vestibular evoked myogenic potentials (VEMPs) 985
Absence of cardiovascular autonomic modulation during Sleep in patients with acute ischeic stroke: an analysis from the SAS-care study cohort 984
The urge to move: From restless legs syndrome to impulse control disorders in Parkinson's disease 972
Occurance and Daergic therapy correlates of REM sleep behaviour disorder in a large population of patients with Parkinson's disease 947
Novel Associations of BST1 and LAMP3 with Rapid Eye Movement Sleep Behavior Disorder 946
Les critères diagnostiques du TCSP sont-ils appropriés chez les patients parkinsoniens ? Une étude par modèle des classes latentes 934
Apathy in Parkinson’s disease is associated with REM sleep behavior disorder 917
Stimolazione del nervo vago in paziente affetto da sclerosi tuberosa. 907
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 901
Polysomnographic markers of REM sleep behavior disorder in Parkinson’s Disease: methodological issues, diagnostic accuracy and progression over time 895
Comparison between automatic and visual scorings of REM sleep without atonia for the diagnosis of REM sleep behavior disorder in Parkinson disease 888
Sleep and REM sleep behaviour disorder in Parkinson’s disease with impulse control disorder 879
Dopamine transporter neuroimaging and clinical predictors for phenoconversion of idiopathic REM sleep behavior disorder to overt synucleinopathy: an international multicenter study 858
Neuropsychological and behavioral profile of patients with sleep-related hypermotor epilepsy (SHE) and patients with disorders of arousal (DOA) 832
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 832
Brain-derived neurotrophic factor Val66Met polymorphism in vagal nerve stimulation patients affected by drug-resistant epilepsy. 808
Sleep‐related hypermotor epilepsy and non‐rapid eye movement parasomnias: Differences in the periodic and aperiodic component of the electroencephalographic power spectra 807
Sleep After Traumatic Brain Injury 783
Shift rotation scheme, sleepiness and sleep quality in night-shift workers 764
Sensitivity and specificity of two screening questionnaires for REM sleep behaviour disorder and relationship with REM sleep without atonia in patients with Parkinson's disease 760
Therapeutic Use of Cerebellar Intermittent Theta Burst Stimulation (iTBS) in a Sardinian Family Affected by Spinocerebellar Ataxia 38 (SCA 38) 741
Comparison between automatic and visual scoring methods of muscle tone during rapid eye movement sleep in Parkinson's disease 721
Time structure of leg movement activity during sleep in untreated Parkinson disease and effects of dopaminergic treatment 696
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 664
COVID-19 lockdown consequences on body mass index and perceived fragility related to physical activity: A worldwide cohort study 656
Association between impulsive-compulsive behaviors and REM sleep behavior disorder in Parkinson's disease: a video-polysomnographic study 654
Sensitivity and specificity of the "REM sleep behavior disorder-single-question screen" (RBD-1Q) in Parkinson's disease 648
Decision making in Parkinson's disease with and without REM sleep behavior disorder 632
Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder 617
Impulse Control Disorders are associated with REM Sleep Behavior Disorder in patients with Parkinson’s Disease: a Video-Polysomnographic Study 595
Changes in Cannabis Consumption During the Global COVID-19 Lockdown: The International COVISTRESS Study 573
Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements in Sleep in the Elderly with and without Dementia 571
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study 569
Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study 555
Totale 163.606
Categoria #
all - tutte 215.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026.479 0 0 0 303 11.062 7.799 3.965 696 487 547 417 1.203
2020/202148.709 1.260 1.569 1.446 14.340 9.558 5.395 3.342 3.217 1.223 2.862 3.257 1.240
2021/202210.351 1.069 697 596 586 849 869 766 448 838 1.045 1.182 1.406
2022/202314.876 1.342 2.004 1.933 1.255 1.248 1.391 861 1.078 842 859 1.365 698
2023/202416.713 870 693 697 1.123 1.524 2.374 2.457 1.082 699 1.146 1.957 2.091
2024/202537.943 15.251 9.702 11.922 1.068 0 0 0 0 0 0 0 0
Totale 177.671